FDA is alerting patients and health care professionals about the voluntary withdrawal of Oxbryta from the market due to safety concerns
[9/26/2024] FDA is alerting patients, caregivers, and health care professionals that Oxbryta (voxelotor)...
FDA working with manufacturers to withdraw Zinbryta from the market in the United States
On March 2, Biogen and Abbvie announced a voluntary withdrawal of Zinbryta (daclizumab), a multiple sclerosis (MS) drug,...